Skip to content

a large US health system with two medication-filling robots

A Large US Health System Insources Medications With Two Filling Robots

How a large US health system paired two medication-filling robots with insourcing, reporting about $2.5M in savings, and what pharmacy leaders can learn.

Deployment at a glance

2
Medication-filling robots at one health system
$2.5M
Savings reported from insourcing and the robots together
In-house
Some medications made in house, not sourced outside

Based on a documented real-world deployment. Figures are from public reporting; the organization is not named.

A pharmacist in a white coat reviews medication preparation work in a hospital pharmacy.
Photo: cottonbro studio

A shortage that exposed the cost of outside supply

The two robots were IV-filling units first designed to address a national shortage of heparin. For a hospital pharmacy, a shortage like that goes beyond inconvenience. It forces hard questions about where critical infusions come from, how reliably they arrive, and what they cost when the supply chain tightens.

The health system faced a choice many pharmacy departments face: keep sourcing certain medications from outside suppliers, or bring that production in house. Insourcing meant taking on the work itself, with staff, supplies and the robotic filling line all sitting inside the pharmacy.

Bringing production in house around two robots

The health system did not treat the robots as a stand-alone upgrade. It insourced some medications and built that work around two IV-filling robots, so the operating model and the equipment changed together.

That combined approach shapes how the result should be read. Savings came from a changed workflow as well as from the machines, which makes the robots one part of a larger decision rather than the whole of it.

Hospital pharmacy staff gather to plan how medication production will work inside their department.
Photo: cottonbro studio

About $2.5 million, from operations and equipment together

The health system reported savings of about $2.5 million. The pharmacy vice president who spoke on the results tied that figure to insourcing some medications instead of sourcing them externally, with the two robots as part of the same change.

Read it as a combined result. Operations, medication supply and robot-based filling moved together, so no single line can be credited to the machines alone. For pharmacy leaders weighing dispensing automation, that is the practical lesson: the financial case is strongest when the workflow around the robot is redesigned with it.

What this means for a robot decision

An empty hospital corridor with clean floors and overhead lights, the kind of site where medication workflows are mapped.
Photo: Manuel Nielsen

Service Robot Co. is a vendor neutral robot integrator for US businesses. We select robots across manufacturers, then lease, deploy, integrate, train and service them through a nationwide US engineer network, with one partner and one number for the whole lifecycle. Our offer is a 3-year robot lease with one fixed robot lease payment, quoted after a site assessment.

The lesson from this health system carries beyond pharmacy. A robot earns its place when the process around it is ready, so the site assessment should map the workflow, staffing and integration points before anyone discusses a figure. Commercial robot leasing works best when selection, deployment and service sit with one accountable team, from the first walk-through to go live support.

Frequently asked questions

No. The health system tied the figure to insourcing some medications as well as to its two robots, so it reflects one combined operations and financial change. A pharmacy building an internal case should keep the operating changes and the equipment in view together.

Want a robot working for you?

Tell us the job and the site. We will recommend the robot, quote the lease, and keep it serviced.

More case studies

Free site assessment. We tell you what actually works before you spend a dollar.